GE Capital

GE Equity is a division of General Electric that focuses on maximizing returns on investment capital through equity investing. It specializes in acquiring minority ownership stakes in established companies with significant growth potential. The division pursues various investment strategies, including growth capital, buy-out co-investments, secondary direct purchases, recapitalizations, and limited partner investments. Leveraging GE's extensive industry knowledge and global reach, GE Equity seeks to identify and capitalize on high-potential opportunities across multiple sectors. By combining financial acumen with operational expertise, GE Equity plays a crucial role in enhancing the overall value of General Electric's investment portfolio.

Todd Cortell

Senior Vice President of Franchise Finance

Joseph Moss

Managing Director

Ned Reynolds

Director, Media Relations - Americas

213 past transactions

Cianna Medical

Debt Financing in 2015
Cianna Medical, Inc., a women’s health company, develops medical technologies for treating breast cancer. The company offers SAVI SCOUT, a wire-free radar localization solution for breast tumor localization; and SAVI Brachy, a solution to deliver a highly-precise dose of radiation only to the tissue where the cancer is likely to reoccur. It also offers BrachyBytes, an e-newsletter that features interviews with experts in breast brachytherapy. The company was incorporated in 2007 and is based in Aliso Viejo, California. As of November 13, 2018, Cianna Medical, Inc. operates as a subsidiary of Merit Medical Systems, Inc.

Cerapedics

Debt Financing in 2015
Cerapedics, Inc. is an orthobiologics company based in Westminster, Colorado, specializing in the development and commercialization of its proprietary small peptide technology platform, specifically the biomimetic peptide molecule known as P-15. The company focuses on creating innovative solutions for spinal applications and orthopedic procedures. Its primary offerings include i-FACTOR, a peptide-enhanced bone graft designed to stimulate the natural bone healing process, and i-FACTOR+ MATRIX for surgical implantation. Founded in 2000, Cerapedics aims to provide safer and more predictable bone formation options compared to traditional bone growth factors, thereby enhancing the effectiveness of spinal fusion surgeries and other orthopedic treatments.

Nobilis Health

Post in 2015
Nobilis Health Corp. is a healthcare development and management company based in Houston, Texas, specializing in the ownership and operation of ambulatory surgical centers (ASCs) and acute-care hospitals across the United States. The company operates through two segments: Medical Services and Marketing. Its facilities offer a range of surgical procedures across various clinical specialties, including orthopedic surgery, pain management, and gynecology. In addition to its surgical services, Nobilis provides marketing, patient education, and care coordination services to third-party healthcare providers. Founded in 2007 and previously known as Northstar Healthcare Inc., Nobilis Health operated 32 locations, including 5 hospitals and 14 ASCs, as of late 2017. However, on October 21, 2019, the company filed for voluntary liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware, indicating significant operational challenges.

USGI Medical

Venture Round in 2015
USGI Medical, Inc. is focused on developing innovative technologies that enable surgeons and gastroenterologists to perform minimally invasive procedures through the body's natural passageways. The company specializes in tools for incisionless surgeries, particularly targeting conditions such as obesity, gastroesophageal reflux disease, and procedures involving natural orifice translumenal endoscopic surgery. Founded in 2001 and headquartered in San Clemente, California, USGI Medical has created the Incisionless Operating Platform (IOP), which allows for the reliable and durable fixation and plication of gastrointestinal tract tissue without the need for external incisions. This approach aims to enhance patient recovery by reducing pain, shortening hospital stays, minimizing the risk of wound infections, and eliminating external scars, thus meeting the growing demand from patients and healthcare providers for less invasive surgical options.

Spiracur

Debt Financing in 2014
Spiracur Inc. is a privately held medical device company established in 2007 through the Stanford Biodesign Innovation Program. The company specializes in creating innovative wound healing technologies aimed at improving patient care and clinician efficiency. Its flagship product, the SNaP Wound Care System, addresses the limitations of traditional negative pressure wound therapies, which can be cumbersome for both patients and healthcare providers. Spiracur focuses on developing solutions that prioritize patient needs and enhance the overall wound care experience.

Schumacher Group

Debt Financing in 2014
Schumacher Group is one of the nation’s largest and fastest-growing health care resources, partnering with more than 3,000 providers to help treat more than 4 million patients annually. Our innovative, patient-centered solutions cover the entire continuum of care, including Emergency Medicine, Hospital Medicine, Care Management and Medical Billing.

CINQS

Debt Financing in 2014
CINQS is a smartphone application company that connects drivers with individuals seeking rides. Established in 2016 and headquartered in Nanterre, France, CINQS offers a platform for private hire car services. The company operates as a subsidiary of CHABÉ Limousines SAS, focusing on providing premium transportation solutions.

Cardiva Medical

Debt Financing in 2014
Cardiva Medical, Inc. is a medical device company that specializes in vascular access management products aimed at facilitating the body's natural healing process after percutaneous catheterization procedures. Its product lineup includes VASCADE VCS, a bioabsorbable femoral access closure system that promotes rapid hemostasis and reduces complications. Additionally, Cardiva offers the Catalyst manual compression assistance device, which supports temporary hemostasis and improves coagulation for patients needing manual compression. The company also manufactures VASCADE MVP, a vascular closure system for multi-site venous closure during electrophysiology procedures such as cardiac ablation. Founded in 2002 and headquartered in Santa Clara, California, Cardiva Medical serves physicians and cardiac centers across the United States.

Infovista

Debt Financing in 2014
InfoVista provides a unified platform for network performance management, application performance management and SLA management that empowers service providers and enterprise IT organizations to holistically and cost-effectively monitor and ensure availability and quality of service on the infrastructure, services and applications they deliver.

USGI Medical

Debt Financing in 2014
USGI Medical, Inc. is focused on developing innovative technologies that enable surgeons and gastroenterologists to perform minimally invasive procedures through the body's natural passageways. The company specializes in tools for incisionless surgeries, particularly targeting conditions such as obesity, gastroesophageal reflux disease, and procedures involving natural orifice translumenal endoscopic surgery. Founded in 2001 and headquartered in San Clemente, California, USGI Medical has created the Incisionless Operating Platform (IOP), which allows for the reliable and durable fixation and plication of gastrointestinal tract tissue without the need for external incisions. This approach aims to enhance patient recovery by reducing pain, shortening hospital stays, minimizing the risk of wound infections, and eliminating external scars, thus meeting the growing demand from patients and healthcare providers for less invasive surgical options.

Amedica

Post in 2014
Amedica is a spinal and orthopedic implant company specializing in the development of implants using silicon nitride ceramic technology. It focuses on creating innovative spinal and total joint implants, leveraging its expertise in the manufacturing and research of silicon nitride ceramics. The company operates an ISO 13485 certified manufacturing facility, where it produces spinal implants that are exclusively distributed through CTL-Amedica, its retail channel. Amedica aims to enhance patient outcomes by utilizing the unique properties of silicon nitride in its medical products.

Cianna Medical

Debt Financing in 2014
Cianna Medical, Inc., a women’s health company, develops medical technologies for treating breast cancer. The company offers SAVI SCOUT, a wire-free radar localization solution for breast tumor localization; and SAVI Brachy, a solution to deliver a highly-precise dose of radiation only to the tissue where the cancer is likely to reoccur. It also offers BrachyBytes, an e-newsletter that features interviews with experts in breast brachytherapy. The company was incorporated in 2007 and is based in Aliso Viejo, California. As of November 13, 2018, Cianna Medical, Inc. operates as a subsidiary of Merit Medical Systems, Inc.

Del Taco

Debt Financing in 2014
At Del Taco, all menu items are prepared to order using fresh ingredients including cheddar cheese grated from 40-pound blocks, handmade pico de gallo salsa, lard-free beans slow cooked from scratch and marinated chicken grilled in the restaurant. The menu includes Mexican offerings of tacos, burritos, quesadillas and nachos as well as American favorites like hamburgers, crinkle-cut fries and shakes. Del Taco also serves breakfast featuring a full line of breakfast burritos.

Cerapedics

Debt Financing in 2014
Cerapedics, Inc. is an orthobiologics company based in Westminster, Colorado, specializing in the development and commercialization of its proprietary small peptide technology platform, specifically the biomimetic peptide molecule known as P-15. The company focuses on creating innovative solutions for spinal applications and orthopedic procedures. Its primary offerings include i-FACTOR, a peptide-enhanced bone graft designed to stimulate the natural bone healing process, and i-FACTOR+ MATRIX for surgical implantation. Founded in 2000, Cerapedics aims to provide safer and more predictable bone formation options compared to traditional bone growth factors, thereby enhancing the effectiveness of spinal fusion surgeries and other orthopedic treatments.

AirXpanders

Debt Financing in 2014
AirXpanders develop technology enabling tissue expansion after reconstructive surgery with an emphasis on breast reconstruction. It addresses current unmet needs for patients who require tissue expansion after reconstructive surgery with the first emphasis on breast reconstruction. Present methods of tissue expansion utilize saline-filled implants that are typically injected on a weekly basis after surgery in order to reach the volume of skin and tissue required for the placement of a permanent breast implant.

SynGen

Series C in 2014
SynGen Inc. specializes in the development, design, and manufacture of cell separation tools aimed at efficiently recovering target cells while depleting contaminants. The company's product portfolio includes advanced medical devices such as the SynGenX-1000 and SynGenX-2000 systems, which are closed sterile processing solutions for isolating stem and progenitor cells from umbilical cord blood and preparing platelet-rich plasma, respectively. Additionally, SynGen offers the CryoPRO-2 cryopreservation/storage bag set and a range of laboratory devices, including the SynGenX-Lab System and CryoPRO Workstation, which facilitate the extraction and preservation of valuable cell populations. The company also provides SynGen DataTrak software for data management and SynGenCellWashPRO for semi-automated cell washing processes. With a focus on innovative engineering, SynGen's products serve critical roles in regenerative medicine, diagnostics, and clinical applications. Established in 2007, SynGen is headquartered in Sacramento, California, with operations extending to Runcorn, United Kingdom, and operates as a subsidiary of ThermoGenesis Corp.

Tangent Medical Technologies

Debt Financing in 2014
Tangent Medical Technologies, a development stage medical device company, was founded in Ann Arbor in 2009 based on technology exclusively licensed from the University of Michigan's Medical Innovation Center. The Company's mission is to improve infusion therapy for patients and healthcare workers with its proprietary, intravenous catheters and associated products. Tangent is led by an experienced, successful management team and the original inventors of the technology. The Company expects to begin generating commercial revenues from its lead product, the NovaCath™ Closed IV Catheter System, in 2012.

WKS Restaurant

Debt Financing in 2014
WKS Restaurant Corporation operates as a franchisee of El Pollo Loco restaurant chain. WKS Restaurant Corporation offers management training programs for hiring purposes. WKS Restaurant Corporation was founded in 1987 and is based in Lakewood, California. WKS Restaurant Corporation has operations in California, Arizona, Denver, and El Paso.

Chromatin

Series E in 2014
Chromatin is a biotechnology company focused on developing and marketing innovative agricultural products, particularly hybrid, drought-tolerant sorghum seeds. By utilizing advanced breeding methodologies and combining diverse sorghum varieties, Chromatin aims to meet the growing demand for sustainable agricultural systems. Its products are designed to thrive in various climates, making them suitable for cultivation on over 80% of the world's agricultural land. This versatility enables farmers to optimize crop production for both traditional agricultural markets and bio-industrial applications, which include the creation of renewable chemicals, materials, and fuels. Through these efforts, Chromatin addresses key societal challenges related to agricultural productivity and renewable energy resources.

RadioShack

Venture Round in 2013
RadioShack.com llc is the online gadget vendor of RadioShack Corp. In July 2001, the company's parent company RadioShack Corp. acquired MicroSoft Corp.'s 25% stake in the company. The divestment comes nearly 2 years after Micro-Soft invested $100 million in the online venture which provided RadioShack.com llc with a prime placement on Microsoft's Network portal and MSN eShop, an online shopping site. The transaction will not affect any strategic agreements between the two companies. RadioShack.com LLC operates as a subsidiary of RadioShack Corp. As of November 19, 2020, RadioShack.com LLC operates as a subsidiary of Retail Ecommerce Ventures LLC.

Drive Medical

Debt Financing in 2013
Drive Medical is one of the fastest growing global distributors of durable medical equipment. The Company markets and distributes its products to customers located throughout North America, Europe, Central America, South America, the Middle East and Asia. Drive has corporate offices and distribution facilities located throughout the United States, Canada, the United Kingdom, Germany, Romania, China and Taiwan. Drive North America Technical Service Center is located in Bohemia, New York. See the "Contact Us" section for all location details. Drive was formed in January 2000 under the name Medical Depot, Inc. Not long after the Company started, the ownership recognized the opportunity to reflect the spirit of the Company and the quality of life it provides to the users of their products, and therefore, changed the name to Drive. This culture and drive led to the significant growth and the formation of a multi-national organization. The continuous growth and expansion is supported by the best professionals in the business, state-of-the-art technology and an undying winning attitude.

Sonitus Medical

Debt Financing in 2013
Sonitus Medical Inc., is a privately held medical device company committed to providing innovative and clinically effective hearing solutions that Otologists, ENTs, and Audiologists can use to help their patients rejoin the conversation of life. As an emerging leader in bone conduction hearing devices, Sonitus Medical currently markets the SoundBite Hearing System, the world's first non-invasive and removable hearing solution that imperceptibly transmits sound via teeth. Relying on the principle of bone conduction, this nearly invisible ITM (in-the-mouth) hearing system is a simple and non-surgical solution that is currently FDA cleared as a prosthetic device for the treatment of single sided deafness and conductive hearing loss. Intended future applications for this platform technology include indications for hearing disorders such as mixed hearing loss and tinnitus, as well as consumer and covert communications. Founded in June 2006, Sonitus Medical is headquartered in San Mateo, California.

Xand

Debt Financing in 2013
Xand is a facilities-based provider specializing in data center managed services and technology solutions tailored for clients with critical operational needs. Established in 1999, the company has built a reputation for designing, constructing, and managing IT infrastructure that enhances the performance and availability of vital applications. Xand offers a range of services including colocation, cloud solutions, enterprise hosting, managed services, and business continuity/disaster recovery, catering to various industries such as education, manufacturing, healthcare, retail, and finance. With a focus on mitigating risks associated with single facilities, Xand operates six data centers, ensuring robust backup and support. The company's commitment to superior engineering and customer service enables clients to improve business performance while effectively managing risk.

Karro Food Group

Private Equity Round in 2013
Karro is a producer of bacon, gammon, fresh pork, frozen sausage, ham and cooked meats. Karro supply high quality meat products to retail, foodservice and manufacturing customers across the UK. Karro process circa 45,000 pigs each week for delivery to the UK’s major supermarkets and wholesale food suppliers markets, all with full supply chain visibility. Our pork is eaten by millions of consumers every year, and is stocked across the country by leading retailers. Karro Food Group headquarters’ are located in Malton, North Yorkshire, and employ circa 3,000 people across our national food production locations.

Skylight

Debt Financing in 2013
Skylight Tools, Inc. operates a digital platform that simplifies the process of home renovations by connecting users with general contractors. Founded in 2016 and based in San Francisco, the company offers a comprehensive renovation management tool that assists clients in selecting contractors, managing budgets, and tracking project progress. Their application facilitates payment processing, invoice reconciliation, and real-time updates on project status. Skylight also provides a financial guarantee, covering half of any budget overruns exceeding 10%. The company aims to enhance the renovation experience through a fully integrated digital process that encompasses planning, material selection, permitting, and construction, specifically targeting the challenges associated with traditional renovation methods.

Plus Therapeutics

Post in 2013
Plus Therapeutics is dedicated to developing and delivering innovative cell-based therapies to improve the quality and length of life. It is a global, public company engaged in the development and commercialization of stem and regenerative cell therapies for the treatment of cardiovascular disease, reconstructive surgery, and other serious, chronic, and life-threatening conditions. Plus Therapeutics pipeline of candidate drug products includes their lead drug product candidates, RNL and DocePLUS, which are being developed in the U.S. by a dedicated and energetic team of biologists, chemists, engineers, physicians, and other professionals.

View

Series E in 2013
View, Inc. specializes in designing and manufacturing glass systems for various sectors, including workplace, healthcare, education, and hospitality. Founded in 2006 and headquartered in Milpitas, California, with manufacturing facilities in Olive Branch, Mississippi, the company focuses on enhancing natural light in buildings through its innovative smart window technology. View's products, known for their energy efficiency and positive impact on human health and productivity, utilize artificial intelligence to automatically adjust to sunlight, optimizing light access while minimizing energy consumption. The company markets its solutions through direct sales and representatives both domestically and internationally, positioning itself as a leader in the smart windows industry.

ASI System Integration

Debt Financing in 2013
ASI System Integration, Inc. is North America’s leading independent provider of IT services and solutions.

Amedica

Debt Financing in 2013
Amedica is a spinal and orthopedic implant company specializing in the development of implants using silicon nitride ceramic technology. It focuses on creating innovative spinal and total joint implants, leveraging its expertise in the manufacturing and research of silicon nitride ceramics. The company operates an ISO 13485 certified manufacturing facility, where it produces spinal implants that are exclusively distributed through CTL-Amedica, its retail channel. Amedica aims to enhance patient outcomes by utilizing the unique properties of silicon nitride in its medical products.

Mayborn Group

Debt Financing in 2013
Mayborn Group is a manufacturer and retailer of baby and infant products based in Newcastle upon Tyne, United Kingdom. The company is best known for its feeding and bottle brand, Tommee Tippee, and offers a diverse range of essential products for children, including diaper bins, baby monitors, breast pumps, feeding bottles, sterilizers, and soothing and hygiene items. Mayborn Group focuses on providing high-quality, affordable solutions to meet the needs of parents and caregivers, ensuring access to important baby supplies.

CardioDx

Private Equity Round in 2012
CardioDx, Inc. is a molecular diagnostics company based in Redwood City, California, focused on developing genomic tests for cardiovascular diseases. The company specializes in assessing conditions such as coronary artery disease (CAD), cardiac arrhythmias, and heart failure. Its flagship product, the Corus CAD test, is a blood-based gene expression test designed to help healthcare providers evaluate whether chest discomfort in non-diabetic patients is due to obstructive CAD. The company's innovations aim to improve treatment decisions, enhance patient outcomes, and reduce healthcare costs by providing actionable genomic information to clinicians. Established in 2003, CardioDx primarily serves customers across the United States.

Hospedia

Venture Round in 2012
Hospedia is a UK-based provider of point-of-care systems that focuses on enhancing the healthcare experience through its media, information, and clinical support software. The company holds a significant market presence, with a 75% share among acute NHS hospitals, and its bedside terminals are installed in over 150 facilities. Hospedia's services cater to approximately 10 million patients, 5 million visitors, and 500,000 healthcare staff annually. By offering bedside communication and multimedia services, Hospedia ensures that patients are both educated and entertained throughout their healthcare journey. This approach allows healthcare professionals to access real-time information, facilitating quicker and safer decision-making.

CardioDx

Private Equity Round in 2012
CardioDx, Inc. is a molecular diagnostics company based in Redwood City, California, focused on developing genomic tests for cardiovascular diseases. The company specializes in assessing conditions such as coronary artery disease (CAD), cardiac arrhythmias, and heart failure. Its flagship product, the Corus CAD test, is a blood-based gene expression test designed to help healthcare providers evaluate whether chest discomfort in non-diabetic patients is due to obstructive CAD. The company's innovations aim to improve treatment decisions, enhance patient outcomes, and reduce healthcare costs by providing actionable genomic information to clinicians. Established in 2003, CardioDx primarily serves customers across the United States.

C8 MediSensors

Series C in 2012
C8 MediSensors, Inc., a San Jose, CA-based developer of non-invasive continuous glucose monitors for diabetic patients.

Redapt

Venture Round in 2012
Redapt is a full service systems integrator that delivers innovative data center infrastructure and cloud solutions tailored to meet your business goals. Whether start-up or Fortune 500, Redapt can help decrease cost and increase the value of your IT. Rely on Redapt and keep your technical talent focused on your business.

MedShape

Debt Financing in 2012
MedShape Solutions, Inc., a medical device company, engages in developing and marketing soft tissue fixation and fracture management devices in the United States. It develops shape memory polyaryletheretherketone devices, including spinal cages and suture anchors for orthopedics. The company was founded in 2007 and is based in Atlanta, Georgia.

Infraredx

Debt Financing in 2011
Infraredx, Inc. is a cardiovascular imaging medical device company focused on diagnosing and treating coronary artery diseases. Based in Burlington, Massachusetts, the company specializes in near-infrared spectroscopy (NIRS) technology, offering products such as the dual-modality NIRS-intravascular ultrasound (IVUS) True Vessel Characterization Imaging System, which identifies and characterizes lipid core coronary plaques. Other key products include the Makoto intravascular imaging system, the Dualpro catheter that combines IVUS and NIRS capabilities, and optical catheters that provide high-resolution images of plaque structures. Infraredx serves hospital sites primarily in the United States and Europe, and it operates as a subsidiary of Goodman USA, Inc. after being founded in 1998 and rebranding from InfraReDx, Inc. in 2012.

Eurofactor

Acquisition in 2011
Provider of credit services. The company offers invoice discounting, invoice factoring and asset based lending services. It also provides credit information and collects overseas payments.

Saladax Biomedical

Debt Financing in 2011
Saladax Biomedical, Inc. focuses on developing and commercializing diagnostic blood tests aimed at enhancing personalized medicine in psychiatry and oncology. Established in 2004 and based in Bethlehem, Pennsylvania, the company offers a range of products under its MyCare line, including MyCare Psychiatry for determining appropriate antipsychotic dosages, MyCare Oncology for optimizing chemotherapy exposure, and MyCare Neurology for assessing neurological drug effects. Key products include My5-FU, MyPaclitaxel, MyDocetaxel, and MyImatinib, which assist healthcare professionals in personalizing treatment for various cancers and other conditions. Saladax markets its tests globally through distributors and direct sales in selected regions, striving to provide rapid and cost-effective solutions that allow clinicians to optimize drug dosing based on individual patient needs.

Huaneng Renewables

Post in 2011
Huaneng Renewables Corporation Limited is a Chinese company focused on generating and selling renewable energy, primarily wind and solar power. Established in November 2002 and headquartered in Beijing, the company operates a significant portfolio of renewable energy projects across China, including 10 wind power plants and multiple solar power facilities. As of December 31, 2018, Huaneng Renewables had an installed capacity of approximately 11,965 megawatts. The company has developed several wind power bases in regions such as Northeast China, Eastern China, and Inner Mongolia, and has pioneered the establishment of various wind testing fields. Being a wholly-owned subsidiary of China Huaneng Group, one of the largest state-owned electric utility companies in China, Huaneng Renewables plays a vital role in advancing the country's renewable energy sector by investing in, constructing, acquiring, and operating projects aimed at increasing the share of clean energy in the national grid.

CardioDx

Private Equity Round in 2011
CardioDx, Inc. is a molecular diagnostics company based in Redwood City, California, focused on developing genomic tests for cardiovascular diseases. The company specializes in assessing conditions such as coronary artery disease (CAD), cardiac arrhythmias, and heart failure. Its flagship product, the Corus CAD test, is a blood-based gene expression test designed to help healthcare providers evaluate whether chest discomfort in non-diabetic patients is due to obstructive CAD. The company's innovations aim to improve treatment decisions, enhance patient outcomes, and reduce healthcare costs by providing actionable genomic information to clinicians. Established in 2003, CardioDx primarily serves customers across the United States.

Datapipe

Debt Financing in 2011
Datapipe is a global provider of security and cloud storage solutions, specializing in managing and securing mission-critical IT services. The company offers a comprehensive suite of services that includes cloud computing, infrastructure as a service, platform as a service, colocation, and data center management. Datapipe operates in key financial and technical markets, including New York metro, Silicon Valley, London, Hong Kong, and Shanghai. It serves a diverse range of industries such as financial services, healthcare, manufacturing, government, publishing, media, and technology. Recognized for its expertise, Datapipe was included in Gartner's 2010 Magic Quadrant for Cloud Infrastructure as a Service and Web Hosting.

NeoVista

Debt Financing in 2011
NeoVista Inc is focused on developing medical technologies aimed at improving the treatment of wet age-related macular degeneration (AMD), a condition that affects over 5 million people globally and is a leading cause of blindness among individuals over the age of 50. The company is engaged in clinical studies to validate its innovative technology, which shows promise in enhancing patient care and alleviating the challenges posed by this debilitating condition for both patients and healthcare providers. Through its efforts, NeoVista aims to significantly impact the quality of life for those affected by wet AMD.

eBioscience

Venture Round in 2011
eBioscience is a prominent provider of reagents essential for immunology and oncology research, specializing in flow cytometry. The company offers a vast array of antibodies, ELISAs, and proteins that support life science research and diagnostics. Recognized as an industry leader, eBioscience is particularly noted for its extensive selection of multicolor flow cytometry reagents, producing over 800 new products annually. Their innovative portfolio encompasses antibodies, fluorochromes, and other reagents tailored for applications in immunology, oncology, cell biology, stem cell biology, and diagnostics. As a privately held entity, eBioscience continues to play a critical role in advancing research capabilities within the pharmaceutical sector.

CareDx

Grant in 2011
CareDx is a molecular diagnostics company headquartered in Brisbane, California, established in 2000. It specializes in developing diagnostic assays that leverage advanced genomics technologies to provide clinically actionable insights into a patient's immune status. The company’s flagship product, AlloMap Molecular Expression Testing, is designed for the management of heart transplant patients, aiding in the assessment of transplant rejection. Beyond heart transplants, CareDx is exploring the potential application of its proprietary molecular expression technology for other organ transplants and conditions related to immune system activity, including autoimmune and chronic inflammatory diseases. The company continues to innovate and develop additional products to enhance patient care in transplantation and related fields.

Loehmann's

Venture Round in 2009
Loehmann's, Inc. is an off-price retailer specializing in designer fashion apparel for both women and men, along with accessories and footwear. Founded in 1921 and headquartered in the Bronx, New York, the company offers a diverse range of products, including ladies' sportswear, dresses, career attire, and casual collections, as well as handbags, jewelry, and shoes for plus sizes, juniors, and children. Loehmann's features merchandise from well-known brands such as Calvin Klein, Diane Von Furstenberg, Kenneth Cole, Dolce & Gabbana, Valentino, Nicole Miller, Anne Klein, Donna Karan, and Michael Kors. The company operates multiple store locations across various states, including Arizona, California, Colorado, Connecticut, Florida, Georgia, Illinois, Maryland, Massachusetts, Michigan, New Jersey, New York, Pennsylvania, Texas, Virginia, and Washington. Loehmann's, Inc. is a subsidiary of Loehmann's Holdings, Inc.

TPI Composites

Series B in 2009
TPI Composites, Inc. manufactures and sells composite wind blades, and related precision molding and assembly systems to original equipment manufacturers. The company also provides composite solutions for the transportation industry. It operates in the United States, Asia, Mexico, Europe, the Middle East, Africa, and India. The company was formerly known as LCSI Holding, Inc. and changed its name to TPI Composites, Inc. in 2008. TPI Composites, Inc. was founded in 1968 and is headquartered in Scottsdale, Arizona.

Calypso Soft Drinks

Venture Round in 2009
They have been in the business for over 125 years, building a reputation in the UK for exceptional quality and customer satisfaction and we pride ourselves on the range that they offer. Most of their drinks are packed full of pure fruit juice like their Aquajuice range, so count as one of your five-a-day and they’re proud to say that a lot of their products are school approved. This means that children up and down the country can choose a healthy drink with their School dinner every day.

Micell Technologies

Series B in 2009
Micell Technologies is a biomedical device company that specializes in the development of interventional cardiology systems for vascular drug delivery. Founded in 1995 and based in North Carolina, the company offers a range of innovative products, including the MiStent, a drug-eluting stent that combines the therapeutic benefits of sirolimus with the characteristics of a bare-metal stent. In addition to MiStent, Micell develops drug-coated balloons for delivering sirolimus to arterial walls during procedures such as percutaneous transluminal angioplasty and stent implantation, as well as bioresorbable scaffolds and peripheral drug-eluting stents. The company's advanced technology utilizes supercritical fluid processes to optimize drug release and enhance healing, aiming to improve safety and clinical outcomes for patients with cardiovascular diseases. Micell also provides clinical trials and health economics services to support its product development and market integration.

SunGard

Debt Financing in 2009
SunGard Data Systems Inc. is a global provider of software and technology services, primarily focused on the financial services industry and public sector. The company operates through four main segments: Financial Systems, Public Sector, Higher Education, and Availability Services. Its Financial Systems segment automates processes related to trading, portfolio management, and investment asset accounting, serving financial institutions, corporate treasuries, and energy companies. The Public Sector segment delivers integrated solutions for K-12 education, government operations, and public safety, addressing the administrative and resource planning needs of various public entities. The Higher Education segment focuses on software and services for colleges and universities, while the Availability Services segment offers recovery and managed services to ensure uninterrupted access to critical IT systems. SunGard's offerings include traditional software, cloud services, and professional consulting, emphasizing tailored solutions for its diverse clientele. Founded in 1983 and based in Wayne, Pennsylvania, SunGard operates internationally, supporting organizations across multiple sectors.

SecureWorks

Series C in 2009
SecureWorks Corp. is a cybersecurity provider that specializes in technology-driven information security solutions designed to protect customers from cyber threats both in the United States and globally. The company offers a range of services, including managed security, threat intelligence, security and risk consulting, and incident response. By leveraging a security information and event management (SIEM) platform, SecureWorks enhances its offerings with artificial intelligence and insights from a team of certified experts, enabling clients to prevent, detect, and respond to security incidents effectively. The company's solutions are tailored for a variety of industries, including financial services, healthcare, and manufacturing, and are delivered primarily through a direct sales organization and partner networks. Founded in 1999 and headquartered in Atlanta, Georgia, SecureWorks operates as a subsidiary of Dell Inc.

Solaredge Technologies

Series B in 2009
SolarEdge Technologies is a prominent player in the solar energy sector, specializing in direct current optimized inverter systems for photovoltaic installations. Founded in 2006, the company has established itself as a leader in the DC power optimizer market, holding over 70% market share. SolarEdge offers a comprehensive range of products, including power optimizers, inverters, and a cloud-based monitoring platform, tailored to various solar market segments, from residential to commercial and utility-scale installations. Its innovative technology enables module-level optimization and monitoring, contributing to the efficiency and affordability of solar energy. The company sells its products directly to solar installers and engineering firms, as well as through distributors and wholesalers. With a global footprint, SolarEdge's installations are present in over 40 countries across five continents, supported by strategic partnerships throughout the solar value chain.

KSK Power Venture

Private Equity Round in 2008
KSK Power Venture is a power project development company based in Hyderabad, India, specializing in the development, ownership, operation, and maintenance of power generation assets. Founded in 2001, the company operates primarily in two segments: project development and power generation. Its portfolio includes several operational power plants, such as the KSK Mahanadi Power plant in Chhattisgarh, which has a capacity of 3,600 megawatts, as well as various other coal, lignite, and natural gas-based plants across India. KSK Power Venture supplies electricity to industrial consumers and state-owned enterprises, focusing on capitalizing on growth opportunities within the Indian power sector. In addition to its core power generation activities, the company also explores natural and mineral resources and engages in investment and financing activities.

Grid Net

Series B in 2008
Grid Net is a provider of software solutions aimed at enhancing smart grid operations for utility companies and their partners. The company's flagship product, the Grid Net Machine-to-Machine Network Operating System, is specifically designed to manage grid devices and facilitate advanced grid applications across various broadband networks, whether public or private and wired or wireless. By focusing on strategic deployments of high-value grid applications, Grid Net enables utilities to achieve immediate returns on investment while ensuring long-term value. The company emphasizes open and interoperable systems that support secure and scalable smart grid services, including smart metering. Headquartered in San Francisco, California, Grid Net also has offices in Sydney, Melbourne, and Tokyo, and is supported by notable investors in the technology and energy sectors.

Mzinga

Series D in 2008
Mzinga is the leading provider of social software, services, and analytics that improve business performance. Through a combination of enterprise-class technology, strategy and online moderation services, Mzinga social solutions enable businesses to increase revenue and lower costs by improving brand visibility, workplace satisfaction, and customer loyalty. Headquartered in Burlington, Massachusetts, Mzinga supports more than 14,000 communities and 2.5 billion monthly social interactions from 40 million unique visitors in 160 countries worldwide. To learn more about Mzinga, visit www.mzinga.com.

Archus Orthopedics

Venture Round in 2008
Archus Orthopedics is focused on the development of implants to treat a variety of spine disorders that result from degenerative changes in the facet joints. Archus Orthopedics offers Total Facet Arthroplasty System, a spinal implant that is designed for patients suffering from lumbar spinal stenosis. Archus Orthopedics was acquired by Facet Solutions in November 2009. Archus Orthopedics was founded in 2001 and is based in Redmond, Washington.

Insightec

Venture Round in 2007
InSightec is the pioneer and global leader in MR guided focused ultrasound technology for image guided acoustic surgery. ExAblate® 2000 system was the first system to use the MR guided focused ultrasound technology. The ExAblate system received CE mark in 2002 and the Food and Drug Administration (FDA) approval in 2004 for the treatment of symptomatic uterine fibroids. ExAblate received the European CE Mark for pain palliation of bone metastases in June 2007 and for adenomyosis in June 2010. This device has won numerous innovation awards and has been used to treat thousands of patients around the world.

KSK Power Venture

Post in 2007
KSK Power Venture is a power project development company based in Hyderabad, India, specializing in the development, ownership, operation, and maintenance of power generation assets. Founded in 2001, the company operates primarily in two segments: project development and power generation. Its portfolio includes several operational power plants, such as the KSK Mahanadi Power plant in Chhattisgarh, which has a capacity of 3,600 megawatts, as well as various other coal, lignite, and natural gas-based plants across India. KSK Power Venture supplies electricity to industrial consumers and state-owned enterprises, focusing on capitalizing on growth opportunities within the Indian power sector. In addition to its core power generation activities, the company also explores natural and mineral resources and engages in investment and financing activities.

Vivid Restaurant Concepts

Venture Round in 2007
Vivid Restaurant Concepts is a company that operates a chain of restaurants across the United States. It specializes in providing a diverse range of cuisines, catering to various tastes and preferences. By focusing on delivering quality food and a pleasant dining experience, Vivid Restaurant Concepts aims to attract a broad customer base and maintain its presence in the competitive restaurant industry.

Micell Technologies

Series A in 2007
Micell Technologies is a biomedical device company that specializes in the development of interventional cardiology systems for vascular drug delivery. Founded in 1995 and based in North Carolina, the company offers a range of innovative products, including the MiStent, a drug-eluting stent that combines the therapeutic benefits of sirolimus with the characteristics of a bare-metal stent. In addition to MiStent, Micell develops drug-coated balloons for delivering sirolimus to arterial walls during procedures such as percutaneous transluminal angioplasty and stent implantation, as well as bioresorbable scaffolds and peripheral drug-eluting stents. The company's advanced technology utilizes supercritical fluid processes to optimize drug release and enhance healing, aiming to improve safety and clinical outcomes for patients with cardiovascular diseases. Micell also provides clinical trials and health economics services to support its product development and market integration.

A123 Systems

Series C in 2007
A123 Systems is a prominent developer and manufacturer of advanced lithium-ion batteries and energy storage systems. The company leverages innovative nanoscale materials initially developed at MIT to create its proprietary Nanophosphate electrode technology, which offers significant advantages over competing high-power technologies. A123's battery cells and electrode designs are engineered to reduce costs per watt and per watt-hour, while also providing higher voltage compared to other long-life battery systems. This results in lower overall pack costs and enhanced price-performance due to the batteries' long lifespan, which minimizes lifecycle costs. A123 Systems serves clients across various industries by delivering efficient power solutions that increase battery life and safety in electronic devices. Competitors in the space include Valence, Saft, and Lion Cells.

Brightcove

Series B in 2006
Brightcove is a provider of cloud-based platforms designed for publishing and distributing digital media. The company's flagship product, Brightcove Video Cloud, allows customers to deliver video content across various internet-connected devices. This platform includes features such as content management, live video streaming, social media integration, advertising and monetization tools, and analytics. Brightcove also offers Zencoder, a cloud-based video encoding service, and Brightcove Once, which enables advanced ad insertion and video stitching. Additional services include Brightcove Gallery for creating video portals, Brightcove Perform for managing video player experiences, and the Brightcove Video Marketing Suite, which supports marketers in enhancing engagement and conversion through video. Founded in 2004 and headquartered in Boston, Massachusetts, Brightcove caters to a diverse clientele, including media companies, broadcasters, digital publishers, and educational institutions, among others.

LipoScience

Series F in 2006
LipoScience, based in Raleigh, North Carolina, specializes in developing in vitro diagnostic tests utilizing nuclear magnetic resonance (NMR) technology. The company's flagship product, the NMR LipoProfile test, quantifies low density lipoprotein particles (LDL-P) in blood samples, offering crucial insights for physicians and patients to tailor heart disease risk management. With more than 8 million tests ordered, LipoScience is at the forefront of personalized diagnostics, providing actionable data that enhances patient care and treatment strategies.

Carmen Systems

Venture Round in 2006
Carmen Systems develops, markets and implements resource optimization solutions for clients found primarily in the transportation industry. Carmen Systems’ software solutions improve our clients’ productivity and bottom-line profitability. Our solutions combine the latest in research and technology and include analysis, simulation, development and implementation. Of approximately 290 employees from 32 nationalities, around one third work with R&D, of these 12 per cent have a PhD. Collaboration with a number of leading universities in different countries further contributes to Carmen Systems’ strength in the field of resource optimization. The company headquarters is in Göteborg, Sweden with offices in Amsterdam, Austin (Texas), Brisbane (Australia), Copenhagen, London, Madrid, Monterrey (Mexico), Montreal, Paris, Singapore and Stockholm. Carmen Systems is owned by its management and employees, GE Commercial Finance, Gilde IT Fund B.V., and InnovationsKapital.

Singulex

Series C in 2006
Singulex, Inc., a biotechnology company, develops and commercializes direct molecular detection technology solutions. Its solutions enable life science researchers and clinicians to understand and manage disease. The company develops biomarker diagnostic systems that can detect and quantify normal and abnormal protein biomarkers. It is conducting pilot studies to validate Erenna BioAssay System, a digital molecule detection platform, which detects and quantifies molecule biomarkers in clinical samples. The company also offers various custom assay services, such as pilot study services, assay prototyping, assay characterization, and assay validation. The company was formerly known as BioProfile Corporation and changed its name to Singulex, Inc in September 2003. Singulex is based in Hayward, California

A123 Systems

Series B in 2006
A123 Systems is a prominent developer and manufacturer of advanced lithium-ion batteries and energy storage systems. The company leverages innovative nanoscale materials initially developed at MIT to create its proprietary Nanophosphate electrode technology, which offers significant advantages over competing high-power technologies. A123's battery cells and electrode designs are engineered to reduce costs per watt and per watt-hour, while also providing higher voltage compared to other long-life battery systems. This results in lower overall pack costs and enhanced price-performance due to the batteries' long lifespan, which minimizes lifecycle costs. A123 Systems serves clients across various industries by delivering efficient power solutions that increase battery life and safety in electronic devices. Competitors in the space include Valence, Saft, and Lion Cells.

RPO

Series B in 2006
RPO, Inc. develops, designs, and manufactures waveguides for the consumer electronics market. The company’s products include digital waveguide touch systems, which is a touch screen solution applied in various products, including gameplayers, cellphones, PDAs, GPS systems, automotive control displays, multimedia players, and tablet personal computers, as well as in ATM’s and gambling machines. It also manufactures polymer optical waveguides on wafer and panel substrates. The company was incorporated in 2005 and is headquartered in San Jose, California. It has a research and development facility in Canberra, Australia; and pilot assembly operations in Sydney, Australia.

Univa

Venture Round in 2005
Univa Corporation specializes in enterprise-class workload management and containerization solutions, designed to optimize the performance of applications, containers, and services. The company offers a range of products, including Univa Grid Engine, a distributed resource management system that enhances resource efficiency in data centers. Its add-ons, such as the Container Edition for managing Docker containers, and License Orchestrator for managing licensed applications, complement this core offering. Univa also provides the Universal Resource Broker, which enables the hosting of big data frameworks, and UniSight Reporting for analytics on resource usage. The company's solutions facilitate the automatic management of workloads across on-premise, hybrid, and cloud infrastructures, helping organizations scale their compute resources effectively. Founded in 2004 and headquartered in Hoffman Estates, Illinois, Univa operates additional offices in Canada and Germany and serves hundreds of clients, managing thousands of applications and running billions of tasks daily. As of September 2020, Univa is a subsidiary of Altair Engineering Inc.

Redfern Integrated Optics

Series C in 2005
Redfern Integrated Optics develops and manufactures optical transmitters based on proprietary PLANEX (Planar External Cavity Laser) technology, which enables high performance at low cost for various applications. RIO planar ECL consists of a gain chip and a planar waveguide circuit (PLC) with Bragg grating which forms a laser cavity. This has significant advantages such as; very narrow spectral linewidth, low phase noise and RIN, optimized chirp, low wavelength sensitivity to temperature and bias current, and low power consumption.

OutlookSoft

Series D in 2005
OutlookSoft is a provider of business planning and performance management solutions, specializing in predictive performance management. The company offers a comprehensive platform that encompasses strategic planning, budgeting, forecasting, statutory consolidation, reporting, analysis, predictive analytics, scorecarding, and dashboards. In addition to its software solutions, OutlookSoft provides consulting, training, implementation, and ongoing support services to its clients. Its offerings are designed to help organizations across various industries—including manufacturing, financial services, and the public sector—measure, manage, and predict their financial and operational performance. Founded in 1999 and headquartered in Stamford, Connecticut, OutlookSoft has additional offices in the United States, the United Kingdom, France, Switzerland, and Italy.

Speed Commerce

Post in 2005
Speed Commerce, Inc. is a provider of e-commerce and fulfillment services for retailers and manufacturers in the United States and Canada. Founded in 1983 and based in Richardson, Texas, the company, formerly known as Navarre Corporation, changed its name in September 2013. Speed Commerce offers a range of services including web platform development and hosting, order management, fulfillment, logistics, and contact center services, all designed to deliver transaction-based solutions and information management tools. The company operates fulfillment centers in Pennsylvania, Ohio, Missouri, and Texas, utilizing advanced automation technologies such as unit sortation, pick-to-pack conveyors, and radio frequency scanning to enhance efficiency and service quality.

Iridian Technologies

Series C in 2005
As of August 11, 2006, Iridian Technologies, Inc. was acquired by Viisage Technology Inc. Iridian Technologies, Inc. engages in the research, development, and marketing of biometric identifiers. It offers PrivateID, an image processing protocol and data standard that enables a proof positive-certified iris camera to capture an image, process it, and prepare it for transport; and KnoWho, an authentication server. The company also provides KnoWho authentication server developer's suite, a set of development tools; cameras; and Proof Positive hardware and software certification programs. Its products provide security for public-use applications, such as passenger travel, border control, national IDs, and election verification, as well as restricted access and information access. The company distributes its authentication server software through integrators and application partners. Iridian Technologies, Inc. was formerly known as IriScan, Inc. and changed its name to Iridian Technologies, Inc. in October 2000. The company was incorporated in 1990 and is based in Moorestown, New Jersey.

Cicis Pizza

Venture Round in 2005
Their story began in 1985 with a single restaurant in Plano, Texas and today has over 450 restaurants in 32 states. Cicis invented the unlimited pizza buffet, and since our beginning we’ve pushed the limits of eating out by saying “yes” to individual tastes and empowering our guests to find the flavors they love.

WIS International

Corporate Round in 2004
WIS International Ltd. is a provider of inventory and data collection services catering to retailers globally. Established in 1967 and headquartered in Mississauga, Canada, the company also has locations in San Diego, California, and Flower Mound, Texas. WIS International offers a range of services including inventory counts, consulting, information management, web reporting, merchandising, analysis, and retail price verification. These services are designed to enhance accuracy, reduce costs, and save management time for clients across various sectors, including retail, healthcare, and government. The company was formerly known as Western Inventory Service Ltd. before rebranding in April 2005.

AGY Therapeutics

Series C in 2004
AGY Therapeutics, Inc. is a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments for central nervous system (CNS) diseases. The company targets neurodegenerative diseases, CNS injuries, stroke, cognitive disorders, and schizophrenia, with a diverse pipeline that includes both clinical and preclinical programs. AGY has developed a proprietary platform for functional gene discovery, which aids in identifying and validating therapeutic targets that can modulate disease progression. Key programs in their pipeline include treatments for stroke, cognitive impairment, and schizophrenia, as well as various antibody and receptor therapies. Founded in 1998 and based in South San Francisco, California, AGY Therapeutics aims to address significant unmet medical needs in the CNS therapeutic landscape.

OutlookSoft

Series D in 2004
OutlookSoft is a provider of business planning and performance management solutions, specializing in predictive performance management. The company offers a comprehensive platform that encompasses strategic planning, budgeting, forecasting, statutory consolidation, reporting, analysis, predictive analytics, scorecarding, and dashboards. In addition to its software solutions, OutlookSoft provides consulting, training, implementation, and ongoing support services to its clients. Its offerings are designed to help organizations across various industries—including manufacturing, financial services, and the public sector—measure, manage, and predict their financial and operational performance. Founded in 1999 and headquartered in Stamford, Connecticut, OutlookSoft has additional offices in the United States, the United Kingdom, France, Switzerland, and Italy.

LipoScience

Series E in 2003
LipoScience, based in Raleigh, North Carolina, specializes in developing in vitro diagnostic tests utilizing nuclear magnetic resonance (NMR) technology. The company's flagship product, the NMR LipoProfile test, quantifies low density lipoprotein particles (LDL-P) in blood samples, offering crucial insights for physicians and patients to tailor heart disease risk management. With more than 8 million tests ordered, LipoScience is at the forefront of personalized diagnostics, providing actionable data that enhances patient care and treatment strategies.

Fiberlink

Series C in 2003
Fiberlink Communications Corporation provides mobility as a service (MaaS) that helps enterprises to connect, control, and secure laptops and mobile devices. Its MaaS Platform helps mobile workers to connect to the Internet and the applications and data they need. The company's MaaS platform is used to perform identity management and authentication services; deploy, monitor, and manage security and connectivity applications on laptops and PCs; view information on compliance status, security events, and connectivity costs; and protect mobile devices and the data from loss, theft, data leakage, hackers, and viruses. Its MaaS360 mobility platform manages security and connectivity services on mobile and remote devices, as well as helps administrators to deploy, monitor, update, and remediate various endpoint security and connectivity applications.
Innovative Spinal Technologies is a company focused on developing advanced solutions for spinal disorders, emphasizing motion preservation and minimally invasive treatments. Founded in 2002 and headquartered in Mansfield, Massachusetts, the company offers a range of products designed to enhance surgical outcomes. Key offerings include the AXIENT Dynamic Fixation system, a pedicle screw-based motion system, and the PARAMOUNT Lumbar Fusion System, which is adaptable for various surgical approaches, including minimally invasive and open procedures. Additionally, the PARAMOUNT MIS Pedicle Screw System caters to both single and multi-level spinal surgeries, while the PARAMOUNT Open Pedicle Screw System is tailored for minimally invasive lumbar fusion needs. The PARAMOUNT VBR system is specifically designed for minimally invasive transforaminal approaches, underscoring the company's commitment to innovative spinal care solutions.

Zilliant

Series B in 2002
Zilliant, Inc. provides price optimization and price management software for manufacturing, distribution, high-tech, and industrial service companies. The company’s pricing software enables manufacturers and distributors to adopt an approach to price analysis, optimization, price list management, quoting, and negotiation. It offers Zilliant Precision Pricing Suite (ZPPS), an enterprise software that combines price segmentation and price optimization science with analytics and process automation software for price management; ZPPS Analytics, which provides segment-specific metrics and KPIs to deliver a view of pricing performance and uncover opportunities to improve; ZPPS Price Optimization that produces price and deal envelope recommendations for various price segment; and ZPPS Price List Manager, which administers price lists and policies, as well as other price instruments, such as discount and markup schedules. The company also provides ZPPS Deal Manager and Deal Manager for Agreements, and ZPPS Price Campaign Manager that provides inline analytics and KPIs for scoring deals against peer group benchmarks and enforces corporate price policies; and ZPPS Pricing Information Manager, which manages product mix and selection in various deals. In addition, Zilliant, Inc. offers deployment strategy and planning, and implementation methodology, as well as Zilliant education services for business and technical users. The company has a strategic alliance with Advanous. Zilliant, Inc. was founded in 1999 and is headquartered in Austin, Texas.

BEELINE Technologies

Venture Round in 2002
BEELINE Technologies is the global software partner for clients requiring integrated autonomous control and navigation technologies for land-based vehicles. Quality assured and agile, we develop integrated solutions across all industries. For more than 10 years, the company’s diverse and experienced teams have worked with original equipment manufacturers and technology organisations, to deliver flexible, leading-edge technology solutions for self-propelled, ground-based vehicles. BEELINE is proud of its pioneering spirit, and its innovative, autonomous solutions are used extensively around the world. BEELINE’s commitment to product innovation continues through its investment in sophisticated technology research and development programs that deliver outstanding solutions to our clients. BEELINE is in an exciting growth phase that continues to build value for its existing clients, whilst applying that experience, knowledge, and capability to new industries and technologies.

Confluent Surgical

Series C in 2002
Confluent Surgical develops products to address the need for surgical sealing and post-surgical adhesion prevention applications.The company provides DuraSeal, an adjunct to sutured dural repair during cranial surgeries to provide watertight closure. The company was founded in 1998 and is headquartered in Waltham, Massachusetts.

IP Communications

Series C in 2002
Dallas-based IP Communications (IPC) has the most extensive broadband network in Texas, Missouri, Oklahoma and Kansas. IP Communications provides wide-area networking services to replace traditional private line, frame relay and ISDN with cost effective packet-based solutions. Our next-generation packet-switched network uses a redundant ATM backbone and advanced switching capabilities to provide high quality bundled communication services to all of our customers.

IntraLuminal Therapeutics

Venture Round in 2002
IntraLuminal Therapeutics is a medical device company provides products for the interventional cardiologist and radiologist to cross and recanalize totally occluded arteries. The company’s platform technology has therapeutic application for various cardiovascular, surgical, neurological, carotid, and men’s and women’s health procedures. IntraLuminal Therapeutics was founded in 1997 and is based in Carlsbad, California.
SoftSwitching Technologies offer the most affordable, effective and scalable power quality and monitoring solutions available on the market. A full array of scalable, battery-free DySC products. I-Sense intelligent sensors that pinpoint time and duration of voltage sags. And Grid Alert™ event notifications—the only global power reporting and notification network in the world.

LaserComm

Series D in 2002
Lasercomm Inc was founded in 1998. The company's line of business includes providing telephone voice and data communications services. LaserComm is a privately held Israeli company. The company has developed a technology which established the foundation of a new breed of photonic components and modules for fiber optic networks. Based on its core competence, LaserComm aims to break new grounds in the field of dispersion management. The company develops products specifically designed to increase bandwidth, improve reliability, and reduce the cost of services provided by long-haul and ultra long-haul carriers.

Achillion

Venture Round in 2002
At Achillion, we are driven to transform the lives of patients and families affected by diseases of the complement system, an integral part of the innate immune system. Scientific and clinical evidence has implicated the complement system, and specifically the complement Alternative Pathway (AP), in numerous devastating diseases and conditions. Our principal focus at Achillion is to advance our clinical-stage portfolio of orally administered factor D inhibitors into late-stage development and potential commercialization for patients with devastating disorders of the complement system.

Mesa Communications Group

Venture Round in 2002
Mesa Communications Group is a network of clustered community towers designed to accommodate wireless communication operators. It provides tower space to the wireless communications industry. The company develops a network of clustered community towers designed to accommodate wireless communication operators, including broadband wireless carriers, and FM and TV broadcasters, as well as paging, government, and other private land mobile radio operators. Mesa Communications Group was founded in 1999 and is based in Falls Church, Virginia.

Catalytic Solutions

Series C in 2002
Catalytic Solutions manufactures and distributes emissions control systems and catalytic products for commercial and industrial applications. It manufactures nanostructured catalysts at its main facility in Oxnard, California. The company’s products are most commonly applied to automobile, diesel engine, and energy markets. Catalytic Solutions has manufacturing facilities in Oxnard, California; Reno, Nevada; Thornhill, Canada; and Malmo, Sweden. Catalytic Solutions, Inc. operates as a subsidiary of Clean Diesel Technologies Inc.

DotCast

Series C in 2002
Dotcast, Inc. is a privately held company focused on developing a high-speed wireless broadband network capable of delivering extensive digital content to consumers and businesses across the United States. The Dotcast Digital Network aims to provide a cost-effective distribution channel for various industries, facilitating direct delivery of products to end users. The company's technology supports cable operators in offering comprehensive digital services by utilizing existing infrastructure and antenna systems for both digital and analog signals. Additionally, Dotcast's terrestrial datacasting solutions allow broadcasters and content providers to transmit high-capacity data streams over the air through established television networks, enhancing the efficiency of digital data distribution.

Intraspect Software

Venture Round in 2001
Intraspect Software specializes in inter-enterprise solutions that enhance collaborative business processes. Founded in 1995 and acquired by Vignette in 2003, the company offers portal collaboration tools that allow users to create shared communities focused on strategic accounts, products, and business processes. Its flagship product, Intraspect 5.5, features architectural improvements suited for inter-enterprise deployments, while C-mail Services facilitate user interaction with Intraspect solutions through effective communication channels. The company’s software is particularly beneficial for industries such as financial services and high technology, enabling cross-functional teams to collaborate and communicate effectively with customers, suppliers, and partners across various organizational and geographic boundaries.

Fluidigm

Series C in 2001
Fluidigm Corporation develops and markets innovative technologies and tools for life sciences research globally. The company specializes in integrated fluidic circuits that control fluids at the nanoscale, enabling a range of applications in biological research. Its product offerings include analytical systems such as the Helios CyTOF system, the Hyperion imaging system, and the Biomark HD system, along with various assays and reagents designed for immuno-oncology and genetic analysis. Fluidigm also provides preparatory instruments and single-cell microfluidics, such as the C1 and Polaris systems. The company serves a diverse clientele, including academic institutions, clinical research laboratories, biopharmaceutical, biotechnology, and agricultural biotechnology companies, focusing on non-diagnostic and non-clinical applications. Established in 1999 as Mycometrix Corporation, it adopted the name Fluidigm Corporation in 2001 and is headquartered in South San Francisco, California.

Citadon

Venture Round in 2001
Citadon is a provider of internet-based project collaboration and business process management services, primarily serving the engineering and construction sector. The company offers a diverse range of solutions, including CAFM explorer, collaboration workspace, docleader, McLaren enterprise, fusion, and OPIDIS. Its services cater to various clients in industries such as construction, oil and gas, life sciences, energy, and nuclear sectors. Founded by Tawfik Hammound, Citadon is headquartered in California and focuses on meeting the needs of architects, engineers, contractors, and facility managers through its innovative project collaboration tools.

NetScreen

Venture Round in 2001
NetScreen, a provider of integrated network security systems, specializes in delivering high-performance firewall, VPN, and traffic management solutions for enterprises and service providers. The company focuses on ensuring security, performance, and cost-effectiveness for its customers. Its products and services are designed to meet the needs of both enterprises and carriers, offering robust internet security systems and appliances that enhance network infrastructure. By prioritizing the security and efficiency of online operations, NetScreen plays a crucial role in safeguarding digital environments for its clientele.

Okena

Series B in 2001
Okena provides enterprise security software. StormWatch, the company’s product, defended against attacks across networks.

AirPrime

Series C in 2001
The company develops code division multiple access chipsets for wireless voice and data products.

United Devices

Series B in 2001
United Devices will add representatives from GE Equity, Constellation Ventures and Oak Investment Partners to its board of directors. United Devices develops software designed to utilize idle computer processing power, storage and bandwidth to give companies more resources in each of these areas.

Premier Retail Networks

Venture Round in 2001
PRN, founded in 1993, is the nation's largest retail media network. PRN works with major retailers to create in-store television and interactive networks that broadcast news and product information, entertainment and advertising to viewers while they shop.

NaviNet

Series C in 2001
NaviNet, Inc. operates a healthcare collaboration network that connects health plans and physicians across the United States. The company's flagship offering, NaviNet Open, provides a comprehensive platform for payer-provider collaboration, facilitating essential healthcare transactions such as eligibility verification, claims management, and authorizations. In addition to NaviNet Open, the company offers various solutions including Insurer Connect, which links users to insurance plans; Payment Management, enabling fund collection; and Patient Care Connect, which fosters collaboration among patients, insurers, and healthcare providers. NaviNet's services encompass claim and payment management, clinical messaging, health record exchange, and provider communications, among others. Established in 1997 and originally named NaviMedix, Inc., the company was rebranded in 2009 and is headquartered in Boston, Massachusetts. As of early 2016, NaviNet operates as a subsidiary of Nanthealth, LLC and NantWorks, LLC.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.